Endocrine Gland Neoplasms  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Endocrine Gland Neoplasms
NCT02090127: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient

No Longer Available
N/A
US
ficlatuzumab, AV-299, SCH 900105
AVEO Pharmaceuticals, Inc.
Mullerian Mixed Tumor of Ovary
 
 
NCT03063710: Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan

No Longer Available
N/A
Japan
olaparib
AstraZeneca
PSR Ovarian Cancer With a BRCA Mutation
 
 

Download Options